SCHEMBL5349352

SCHEMBL5349352

CCCC(=O)NCCc1cccc2ccc(O)cc12

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 13/20 0.74
MTNR1B P49286 5/20 0.74
NQO2 P16083 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075316 0.92 MTNR1A (0.74) MTNR1AMTNR1BNQO2
SCHEMBL6075441 0.89 MTNR1A (0.62) MTNR1AMTNR1BNQO2
SCHEMBL9126868 0.87 MTNR1A (0.74) MTNR1AMTNR1BNQO2
SCHEMBL6076693 0.86 MTNR1A (0.72) MTNR1AMTNR1BNQO2
SCHEMBL27436070 0.85 NQO2 (0.73) MTNR1AMTNR1BNQO2
SCHEMBL5345535 0.85 NQO2 (0.73) MTNR1AMTNR1BNQO2
SCHEMBL30449793 0.85 MTNR1A (1.00) MTNR1AMTNR1BNQO2
SCHEMBL4043404 0.85 MTNR1A (1.00) MTNR1AMTNR1BNQO2
SCHEMBL6495378 0.85 MTNR1A (0.67) MTNR1AMTNR1B
SCHEMBL7105897 0.85 MTNR1A (0.70) MTNR1AMTNR1BNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123529-A1 Substituted biphenyl compounds LES LABORATOIRES SERVIER (FR) 2007-05-31 US disclosed
US-7161035-B2 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2007-01-09 US disclosed
CN-1233621-C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB (FR) 2005-12-28 CN disclosed
EP-1317413-B1 SUBSTITUTED BIPHENYL DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2005-08-24 EP disclosed
US-20040014969-A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2004-01-22 US disclosed
CN-1457337-A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same SERVIER LAB (FR) 2003-11-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014969-A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same MTNR1A, MTNR1B, MC2R MTNR1A 1/4885MTNR1B 2/4885NQO2 406/4885
US-20070123529-A1 Substituted biphenyl compounds MTNR1A, MTNR1B, CNR1 MTNR1A 1/4885MTNR1B 2/4885NQO2 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.